# Phase 3 Patient First Slice

Phase 3 is implemented mobile-first with a matching lightweight web client.

## Implemented

- Patient signup and patient/doctor password login with role verification.
- Persisted React Native sessions using AsyncStorage.
- Consent/privacy gate stored in `user_profiles.consent_accepted_at`.
- Seven-day patient timeline backed by RLS-protected `patient_entries`.
- Timestamped text entry creation, reload, timestamp editing, and deletion.
- Loading, success, empty, validation, and failure states.
- Shared Supabase auth, profile, and entry operations for mobile and web.
- All new visible interface text is available through shared English/Serbian keys.
- No Google Play Services dependency was introduced.

## Verification

- Root TypeScript check passed.
- ESLint passed.
- Prettier check passed.
- Five focused unit tests passed.
- Web production build passed.
- Expo Android export passed.
- Expo dependency compatibility check passed with one deduplicated React and
  React Native runtime.
- Web preview checked at 412x915, 320x568, and 1280x720 with no horizontal
  overflow or browser console errors.

## Remaining Guided Acceptance

- Create or use a test patient account in the configured Supabase project.
- Accept consent, save an entry, reload, edit its timestamp, and delete it.
- Measure online text-save response against the two-second target.
- Confirm email signup behavior matches the project's Auth email-confirmation
  setting.

An APK/device smoke test remains part of final Android validation rather than
this Metro bundle verification.

`npm audit --omit=dev` currently reports ten moderate findings through Expo's
Xcode/config tooling and `uuid`. npm only offers a forced downgrade to Expo 46,
so no breaking automated audit fix was applied.
